#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	542	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1204	23.6	0	.	p	.	0	K29T	NONSYN	85	87	AAG	346	348	ACG	28;27;29	A;C;G	28;27;29	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	187	1994	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1410	68.7	1	SNP	p	R234F	1	.	.	700	702	TTC	878	880	TTC	93;95;95	T;T;C	93;95;95	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	187	1994	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1410	68.7	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1178	1180	CGT	87;89;89	C;G;T	86;89;87	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	187	1994	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1410	68.7	0	HET	.	.	.	T999C	.	999	999	T	1177	1177	T	82	T,C	41,40	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	187	1994	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1410	68.7	0	HET	.	.	.	T180C	.	180	180	T	358	358	T	58	T,C	34,17	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	187	1994	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1410	68.7	0	HET	.	.	.	C261T	.	261	261	C	439	439	C	65	C,T	38,27	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	906	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	2008	23.9	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1640	1642	AAA	20;19;19	A;A;A	20;19;18	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	956	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c4.ctg.1	1873	27.0	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1317	1319	GAA	30;30;30	G;A;A	30;30;30	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	238	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	659	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	154	G	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	145	C	145	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	140	C	140	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	146	T,C	145,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	136	C	136	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	111	C	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	120	A,C	119,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	118	A	118	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	113	A	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	110	T,G	107,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	107	C	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	106	C	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	102	A	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	96	G	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	97	C	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	102	T,A	101,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	127	G	127	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	129	G	129	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	129	T	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	141	T	141	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	129	G	129	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	107	C	107	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	99	A	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	70	C	69	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	67	C	66	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	18	A	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	18	A	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	20	G	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	26	C	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	68	T	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	82	G	82	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	84	T	84	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	2820	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	734	99.2	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	149	C	146	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	800	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1651	25.7	0	.	p	.	0	H2R	NONSYN	4	6	CAT	256	258	CGT	23;24;23	C;G;T	23;24;23	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	800	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1651	25.7	0	.	p	.	0	V30I	NONSYN	88	90	GTC	340	342	ATC	49;49;49	A,C;T;C	48,1;49;49	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	800	PmrB_1	1092	1092	99.08	PmrB_1.l6.c30.ctg.1	1651	25.7	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1099	1101	GGC	31;32;32	G;G;C	31;32;32	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1050	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2117	26.4	0	.	p	.	0	R8S	NONSYN	22	24	AGA	272	274	AGC	15;13;14	A;G;C	14;13;14	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1050	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2117	26.4	0	.	p	.	0	I142L	NONSYN	424	426	ATA	674	676	CTA	27;28;29	C,A;T,A;A	25,1;27,1;29	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1050	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2117	26.4	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1193	1195	CAA	30;32;34	C;A;A	30;32;34	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1050	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2117	26.4	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1292	1294	GGT	46;46;46	G;G;T	46;45;46	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1050	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2117	26.4	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1862	1864	GTT	15;15;14	G;T;T	15;15;14	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	556	PmrE	1167	1167	96.83	PmrE.l6.c17.ctg.1	1817	16.4	0	.	p	.	0	A125E	NONSYN	373	375	GCA	702	704	GAA	11;10;11	G;A;A	11;10;11	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	556	PmrE	1167	1167	96.83	PmrE.l6.c17.ctg.1	1817	16.4	0	.	p	.	0	M185T	NONSYN	553	555	ATG	882	884	ACC	16;16;16	A;C;C	16;16;16	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	556	PmrE	1167	1167	96.83	PmrE.l6.c17.ctg.1	1817	16.4	0	.	p	.	0	S225T	NONSYN	673	675	TCC	1002	1004	ACT	10;10;10	A;C;T	10;10;10	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	556	PmrE	1167	1167	96.83	PmrE.l6.c17.ctg.1	1817	16.4	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1392	1394	ATC	13;13;14	A;T;C	13;13;14	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	640	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1543	22.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	62	TEM_1+	858	223	99.1	TEM_1+.l6.c30.ctg.1	223	3.6	0	.	p	.	0	V82I	NONSYN	244	246	GTT	207	209	ATT	1;1;1	A;T;T	1;1;1	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	62	TEM_1+	858	141	100.0	TEM_1+.l6.c30.ctg.2	141	3.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2066	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3545	31.0	0	.	p	.	0	T85I	NONSYN	253	255	ACC	477	479	ATC	34;35;35	A;T;C	34;35;35	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2066	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3545	31.0	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2190	2192	AAG	20;22;22	A;A;G,C	20;22;21,1	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	738	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1553	24.8	0	.	p	.	0	A22V	NONSYN	64	66	GCC	252	254	GTC	13;15;13	G;T;C	13;15;13	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	738	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1553	24.8	0	.	p	.	0	S269C	NONSYN	805	807	AGC	993	995	TGC	29;28;28	T;G;C	29;28;28	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1878	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2974	33.4	0	.	p	.	0	S46trunc	TRUNC	136	136	T	300	300	T	21	T	21	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1878	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2974	33.4	0	.	p	.	0	G148D	NONSYN	442	444	GGC	606	608	GAC	37;34;34	G;A;C	37;34;34	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1878	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2974	33.4	0	.	p	.	0	F240L	NONSYN	718	720	TTT	882	884	TTA	25;25;25	T;T;A	25;25;24	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1878	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2974	33.4	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1065	1067	AAT	33;33;33	A;A;T	33;33;33	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1878	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2974	33.4	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1852	1852	T	44	T	42	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	422	acrR_2	648	648	99.54	acrR_2.l6.c17.ctg.1	1271	17.6	1	SNP	p	R45C	0	.	.	133	135	CGC	445	447	CGC	32;30;27	C;G;C	32;30;27	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	436	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1251	18.5	0	.	p	.	0	L34F	NONSYN	100	102	CTC	394	396	TTC	10;11;11	T;T;C	10;11;11	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	436	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1251	18.5	0	.	p	.	0	E122G	NONSYN	364	366	GAG	658	660	GGG	25;24;24	G;G;G	25;24;24	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	580	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1283	23.9	0	.	p	.	0	V136L	NONSYN	406	408	GTT	685	687	CTT	51;49;48	C;T;T	51;49;48	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1994	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3120	34.1	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2091	2093	GCA	39;40;40	G;C;A	37;39;40	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1994	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3120	34.1	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2352	2354	ACC	49;49;50	A;C;C	46;49;50	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1994	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3120	34.1	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2661	2663	GCC	27;25;25	G;C;C	26;24;25	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	952	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2452	20.7	0	.	p	.	0	G37A	NONSYN	109	111	GGT	296	298	GCT	6;6;6	G;C;T	6;6;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	952	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2452	20.7	0	.	p	.	0	D77E	NONSYN	229	231	GAT	416	418	GAG	7;7;7	G;A;G	7;7;7	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	952	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2452	20.7	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	452	454	TGC	7;8;8	T;G;C	7;8;8	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	952	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2452	20.7	0	.	p	.	0	I150V	NONSYN	448	450	ATT	635	637	GTT	14;14;15	G;T;T	14;14;15	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	952	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2452	20.7	0	.	p	.	0	R200H	NONSYN	598	600	CGC	785	787	CAC	18;19;19	C;A;C	18;19;19	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	952	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2452	20.7	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1070	1072	ATG	24;25;26	A;T;G	23;25;25	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	952	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2452	20.7	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2066	2068	CGC	13;14;14	C;G;C	12;14;14	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	492	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1247	20.5	0	.	p	.	0	S221T	NONSYN	661	663	AGC	878	880	ACC	10;9;10	A;C;C	10;9;10	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	492	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1247	20.5	0	.	p	.	0	P225S	NONSYN	673	675	CCG	890	892	TCG	14;16;17	T;C;G	14;16;17	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	500	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1229	21.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	716	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1591	23.0	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1284	1286	AAA	24;24;23	A;A;A	20;20;23	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	716	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1591	23.0	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1296	1298	GAG	17;17;17	G;A;G	15;14;14	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	716	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1591	23.0	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1302	1304	CAC	17;19;19	C;A;C	15;18;19	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	716	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1591	23.0	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1356	1358	GAG	28;26;25	G;A;G	28;26;24	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	902	cpxA	1374	1374	98.91	cpxA.l15.c17.ctg.1	1936	24.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	598	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1199	26.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	652	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1400	24.5	0	.	p	.	0	A146T	NONSYN	436	438	GCT	660	662	ACT	38;37;38	A;C;T	38;37;37	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	368	dfrA1_1	474	474	100.0	dfrA1_1.l6.c4.ctg.1	1172	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	760	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1649	24.5	0	.	p	.	0	I219V	NONSYN	655	657	ATC	923	925	GTC	31;31;30	G;T;C	29;29;29	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1110	emrB	1539	1539	99.74	emrB.l6.c17.ctg.1	2048	28.7	0	.	p	.	0	E197K	NONSYN	589	591	GAA	850	852	AAA	31;31;31	A;A;A	31;31;31	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	720	emrD	1191	1191	98.4	emrD.l15.c17.ctg.1	1675	22.7	0	.	p	.	0	G209S	NONSYN	625	627	GGC	912	914	AGC	25;24;25	A;G;C	25;23;25	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	46	emrE_1	333	169	90.53	emrE_1.l6.c30.ctg.1	169	2.6	0	.	p	.	0	I100V	NONSYN	298	300	ATT	142	144	GTC	1;1;1	G;T;C	1;1;1	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	46	emrE_1	333	169	90.53	emrE_1.l6.c30.ctg.1	169	2.6	0	.	p	.	0	T108A	NONSYN	322	324	ACA	166	168	GCA	1;1;1	G;C;A	1;1;1	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	664	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1750	20.2	0	.	p	.	0	K176R	NONSYN	526	528	AAG	852	854	AGG	22;22;22	A;G;G	22;22;22	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	664	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1750	20.2	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1242	1244	GAC	15;14;14	G;A;C	15;14;14	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	382	emrR	531	531	100.0	emrR.l15.c17.ctg.1	1196	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	970	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2034	25.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	368	evgA	615	615	99.19	evgA.l6.c30.ctg.1	1136	17.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	437	439	CTG	25;26;23	C;T;G	25;26;23	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	T38I	NONSYN	112	114	ACA	390	392	ATA	9;7;6	A;T;A	9;7;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	L42V	NONSYN	124	126	CTA	402	404	GTA	14;14;15	G;T;A	14;14;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	A93T	NONSYN	277	279	GCG	555	557	ACG	19;18;18	A;C;G	19;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	A114E	NONSYN	340	342	GCA	618	620	GAA	20;20;20	G;A;A	20;20;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	T127A	NONSYN	379	381	ACT	657	659	GCT	20;20;20	G;C;T	20;20;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	N133D	NONSYN	397	399	AAT	675	677	GAT	19;19;20	G;A;T	19;19;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	P162S	NONSYN	484	486	CCA	762	764	TCA	20;20;19	T;C;A	20;20;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	891	893	CAG	20;19;17	C;A;G	20;19;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1029	1031	GTT	11;11;11	G;T;T	11;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1185	1187	GAT	11;10;11	G;A;T	11;10;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1353	1355	AAT	9;9;9	A;A;T	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1374	1376	TTA	6;6;6	T;T;A	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1575	1577	AAA	19;18;18	A;A;A	19;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2310	2312	CAT	23;24;24	C;A;T	22;23;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2364	2366	CAT	17;16;16	C;A;T	17;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2382	2384	AGA	22;22;22	A;G;A	22;22;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2397	2399	AAT	22;21;23	A;A;T	22;21;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2544	2546	TCC	13;16;16	T;C;C	13;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2709	2711	ATT	19;19;17	A;T;T	19;19;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2730	2732	GAT	15;15;17	G;A;T	15;15;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2844	2846	GTT	27;27;29	G;T;T	27;27;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1828	evgS	3594	3594	97.5	evgS.l6.c4.ctg.1	4128	23.5	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3129	3131	CAC	32;32;31	C;A;C	32;32;31	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	590	folP_1	849	849	99.29	folP_1.l6.c17.ctg.1	1512	20.9	1	SNP	p	P64A	0	.	.	190	192	CCA	528	530	CCA	47;47;46	C;C;A	46;46;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	590	folP_1	849	849	99.29	folP_1.l6.c17.ctg.1	1512	20.9	1	SNP	p	P64H	0	.	.	190	192	CCA	528	530	CCA	47;47;46	C;C;A	46;46;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	590	folP_1	849	849	99.29	folP_1.l6.c17.ctg.1	1512	20.9	1	SNP	p	P64R	0	.	.	190	192	CCA	528	530	CCA	47;47;46	C;C;A	46;46;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	590	folP_1	849	849	99.29	folP_1.l6.c17.ctg.1	1512	20.9	1	SNP	p	P64S	0	.	.	190	192	CCA	528	530	CCA	47;47;46	C;C;A	46;46;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	590	folP_1	849	849	99.29	folP_1.l6.c17.ctg.1	1512	20.9	1	SNP	p	P64L	0	.	.	190	192	CCA	528	530	CCA	47;47;46	C;C;A	46;46;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	392	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1126	18.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	332	93.07	gadW.l6.c4.ctg.1	332	6.4	0	.	p	.	0	L46P	NONSYN	136	138	CTG	11	13	CCG	2;2;2	C;C;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	332	93.07	gadW.l6.c4.ctg.1	332	6.4	0	.	p	.	0	E54D	NONSYN	160	162	GAA	35	37	GAT	5;5;6	G;A;T	5;5;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	332	93.07	gadW.l6.c4.ctg.1	332	6.4	0	.	p	.	0	I88M	NONSYN	262	264	ATA	137	139	ATG	3;3;3	A;T;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	332	93.07	gadW.l6.c4.ctg.1	332	6.4	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	140	142	CCG	3;3;3	C;C;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	332	93.07	gadW.l6.c4.ctg.1	332	6.4	0	.	p	.	0	D100E	NONSYN	298	300	GAC	173	175	GAA	1;1;1	G;A;A	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	332	93.07	gadW.l6.c4.ctg.1	332	6.4	0	.	p	.	0	P101S	NONSYN	301	303	CCC	176	178	TCC	1;1;1	T;C;C	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	332	93.07	gadW.l6.c4.ctg.1	332	6.4	0	.	p	.	0	R102G	NONSYN	304	306	CGG	179	181	GGG	1;2;2	G;G;G	1;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	332	93.07	gadW.l6.c4.ctg.1	332	6.4	0	.	p	.	0	K110N	NONSYN	328	330	AAA	203	205	AAT	2;2;2	A;A;T	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	114	gadW	729	140	97.14	gadW.l6.c4.ctg.3	140	15.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	408	gadX	825	825	97.94	gadX.l15.c30.ctg.2	1121	18.5	0	.	p	.	0	F53L	NONSYN	157	159	TTC	435	437	TTA	23;23;22	T;T;A	23;23;22	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	408	gadX	825	825	97.94	gadX.l15.c30.ctg.2	1121	18.5	0	.	p	.	0	V79I	NONSYN	235	237	GTT	513	515	ATT	20;19;19	A;T;T	20;19;19	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	408	gadX	825	825	97.94	gadX.l15.c30.ctg.2	1121	18.5	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1014	1016	GGA	19;19;18	G;G;A	19;19;17	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	408	gadX	825	825	97.94	gadX.l15.c30.ctg.2	1121	18.5	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1020	1022	CCG	18;18;17	C;C;G	18;18;17	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1838	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3228	30.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2336	2338	GAA	31;31;31	G;A;A	31;28;31	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1838	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3228	30.3	1	SNP	p	S83L	0	.	.	247	249	TCG	551	553	TCG	44;38;38	T,G;C;G	39,1;35;36	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1838	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3228	30.3	1	SNP	p	S83I	0	.	.	247	249	TCG	551	553	TCG	44;38;38	T,G;C;G	39,1;35;36	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1838	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3228	30.3	1	SNP	p	S83W	0	.	.	247	249	TCG	551	553	TCG	44;38;38	T,G;C;G	39,1;35;36	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1838	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3228	30.3	1	SNP	p	D87N	0	.	.	259	261	GAC	563	565	GAC	38;39;39	G;A;C	35;37;37	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1838	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3228	30.3	1	SNP	p	D87G	0	.	.	259	261	GAC	563	565	GAC	38;39;39	G;A;C	35;37;37	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1838	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3228	30.3	1	SNP	p	D87H	0	.	.	259	261	GAC	563	565	GAC	38;39;39	G;A;C	35;37;37	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1838	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3228	30.3	1	SNP	p	D87V	0	.	.	259	261	GAC	563	565	GAC	38;39;39	G;A;C	35;37;37	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1838	gyrA_7	2628	2628	98.71	gyrA_7.l6.c4.ctg.1	3228	30.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	563	565	GAC	38;39;39	G;A;C	35;37;37	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1506	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2862	28.1	1	SNP	p	R136S	0	.	.	406	408	CGC	647	649	CGC	32;35;35	C;G;C	32;35;35	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1506	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2862	28.1	1	SNP	p	R136E	0	.	.	406	408	CGC	647	649	CGC	32;35;35	C;G;C	32;35;35	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1506	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2862	28.1	1	SNP	p	R136G	0	.	.	406	408	CGC	647	649	CGC	32;35;35	C;G;C	32;35;35	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1506	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2862	28.1	1	SNP	p	R136C	0	.	.	406	408	CGC	647	649	CGC	32;35;35	C;G;C	32;35;35	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1506	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2862	28.1	1	SNP	p	R136H	0	.	.	406	408	CGC	647	649	CGC	32;35;35	C;G;C	32;35;35	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1506	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2862	28.1	1	SNP	p	R136I	0	.	.	406	408	CGC	647	649	CGC	32;35;35	C;G;C	32;35;35	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1506	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2862	28.1	1	SNP	p	R136L	0	.	.	406	408	CGC	647	649	CGC	32;35;35	C;G;C	32;35;35	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	374	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1139	17.1	0	.	p	.	0	A72P	NONSYN	214	216	GCG	430	432	CCG	15;15;15	C;C;G	15;15;15	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	374	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1139	17.1	0	.	p	.	0	T123A	NONSYN	367	369	ACC	583	585	GCC	16;16;17	G;C;C	16;16;17	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	646	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1524	22.6	0	.	p	.	0	P9S	NONSYN	25	27	CCA	316	318	TCA	18;18;18	T;C;A	18;16;18	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	302	marA	384	384	99.74	marA.l6.c4.ctg.1	973	16.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	578	580	AGC	19;18;17	A;G;C	19;18;17	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	680	682	CAT	9;8;8	C;A;T	9;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	V45E	0	.	.	133	135	GTG	404	406	GTG	26;27;26	G;T;G	26;27;26	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	I49S	0	.	.	145	147	ATC	416	418	ATC	26;26;26	A;T;C	26;26;26	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	A70T	0	.	.	208	210	GCA	479	481	GCA	22;22;22	G;C;A	22;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	R73S	0	.	.	217	219	CGT	488	490	CGT	24;24;24	C;G;T	24;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	R73C	0	.	.	217	219	CGT	488	490	CGT	24;24;24	C;G;T	24;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	R77L	0	.	.	229	231	CGC	500	502	CGC	22;20;18	C;G;C	22;20;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	R77C	0	.	.	229	231	CGC	500	502	CGC	22;20;18	C;G;C	22;20;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	L78M	0	.	.	232	234	CTG	503	505	CTG	18;18;17	C;T;G	18;18;17	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	R94H	0	.	.	280	282	CGC	551	553	CGC	21;22;22	C;G;C	21;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	R94S	0	.	.	280	282	CGC	551	553	CGC	21;22;22	C;G;C	21;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l6.c4.ctg.1	878	12.9	1	SNP	p	V96E	0	.	.	286	288	GTA	557	559	GTA	23;23;23	G;T;A	23;23;23	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	S7F	NONSYN	19	21	TCC	37	39	TTC	3;3;3	T;T;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	R36I	NONSYN	106	108	AGG	124	126	ATC	9;8;8	A;T;C	8;8;8	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	E42A	NONSYN	124	126	GAA	142	144	GCC	7;7;7	G;C;C	7;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	N43V	NONSYN	127	129	AAT	145	147	GTG	7;7;7	G;T;G	7;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	E52D	NONSYN	154	156	GAG	172	174	GAT	9;8;8	G;A;T	9;8;8	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	N59T	NONSYN	175	177	AAC	193	195	ACC	8;8;7	A;C;C	8;8;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	I68L	NONSYN	202	204	ATA	220	222	TTA	12;9;10	T;T;A	11;9;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	361	363	CAG	28;27;26	C;A;G	28;27;26	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	D128A	NONSYN	382	384	GAC	400	402	GCC	17;18;18	G;C;C	17;18;18	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	S163A	NONSYN	487	489	TCG	505	507	GCG	30;31;32	G;C;G	30;31;31	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	L231V	NONSYN	691	693	CTT	709	711	GTT	9;10;10	G;T;T	7;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	514	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1509	18.1	0	.	p	.	0	R285fs	FSHIFT	853	853	C	871	871	C	23	C	23	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	614	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1707	19.0	0	.	p	.	0	V12trunc	TRUNC	34	34	G	256	256	G	31	G	31	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	614	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1707	19.0	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	313	315	CAG	15;15;14	C;A;G	14;15;13	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	614	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1707	19.0	0	.	p	.	0	T83I	NONSYN	247	249	ACC	463	465	ATC	14;14;12	A;T;C	12;13;12	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	614	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1707	19.0	0	.	p	.	0	I99M	NONSYN	295	297	ATA	511	513	ATG	13;13;13	A;T;G	13;13;12	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	614	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1707	19.0	0	.	p	.	0	A130T	NONSYN	388	390	GCC	604	606	ACC	17;17;16	A;C;C	17;17;16	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	614	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1707	19.0	0	.	p	.	0	P257T	NONSYN	769	771	CCG	985	987	ACG	23;24;23	A;C;G	23;24;23	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2144	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3462	32.8	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1976	1978	ACC	47;46;45	A;C;C	45;45;44	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2144	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3462	32.8	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2369	2371	CAA	28;28;27	C;A;A	27;28;26	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2144	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3462	32.8	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2537	2539	ATT	20;20;20	A;T;T	20;20;20	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2144	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3462	32.8	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2621	2623	GTT	26;26;27	G;T;T	26;26;27	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2144	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3462	32.8	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2729	2731	GAG	28;27;27	G;A;G	28;27;27	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2144	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3462	32.8	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2957	2959	ATG	18;19;18	A;T;G	18;19;17	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2144	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3462	32.8	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3092	3094	GAT	32;31;31	G;A;T	32;30;31	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1856	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3286	29.6	0	.	p	.	0	I46M	NONSYN	136	138	ATC	322	324	ATG	12;12;12	A;T;G	12;11;12	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1856	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3286	29.6	0	.	p	.	0	V208I	NONSYN	622	624	GTC	808	810	ATC	32;32;29	A;T;C	32;32;29	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1856	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3286	29.6	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3124	3126	CAC	8;8;6	C;A;C	7;7;6	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1856	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3286	29.6	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3127	3129	CTC	6;6;7	C;T;C	6;6;7	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	878	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1848	25.1	0	.	p	.	0	D3E	NONSYN	7	9	GAT	173	175	GAA	11;14;14	G;A;A	11;14;14	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	878	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1848	25.1	0	.	p	.	0	T226A	NONSYN	676	678	ACG	842	844	GCG	22;21;22	G;C;G	21;21;22	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	878	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1848	25.1	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1184	1186	ATC	30;31;32	A;T;C	30;31;32	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	878	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1848	25.1	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1487	1489	TTT	36;36;35	T;T;T	36;36;35	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	970	mdtE	1158	1158	99.31	mdtE.l6.c4.ctg.1	1573	32.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2084	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3745	29.7	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1215	1217	ACC	24;24;25	A;C,A;C	24;22,1;25	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2084	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3745	29.7	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2457	2459	GAC	29;31;29	G;A;C	28;31;29	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	766	mdtG	1227	1047	99.33	mdtG.l6.c17.ctg.1	1570	21.6	0	.	p	.	0	V200I	NONSYN	598	600	GTC	693	695	ATC	17;17;16	A;T;C	17;17;16	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	766	mdtG	1227	177	99.44	mdtG.l6.c17.ctg.2	391	11.3	0	.	p	.	0	E5G	NONSYN	13	15	GAA	8	10	GGA	3;3;3	G;G;A	3;3;3	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	702	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1672	22.4	0	.	p	.	0	G134C	NONSYN	400	402	GGT	681	683	TGT	30;31;32	T;G;T	30;31;32	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	702	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1672	22.4	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1251	1253	TTG	14;14;15	T;T;G	14;14;14	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	702	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1672	22.4	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1461	1463	ACG	6;6;6	A;C;G	5;5;6	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	732	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1708	22.8	0	.	p	.	0	A185S	NONSYN	553	555	GCC	795	797	TCC	20;19;20	T;C;C	20;19;20	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	526	mdtN	1032	1032	98.02	mdtN.l15.c30.ctg.1	1511	18.4	0	.	p	.	0	V119I	NONSYN	355	357	GTT	567	569	ATT	14;14;14	A;T;T	14;14;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1118	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2465	24.1	0	.	p	.	0	V11M	NONSYN	31	33	GTG	204	206	ATG	14;16;16	A;T;G	14;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1118	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2465	24.1	0	.	p	.	0	T33I	NONSYN	97	99	ACC	270	272	ATC	12;13;13	A;T;C	12;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1118	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2465	24.1	0	.	p	.	0	C116R	NONSYN	346	348	TGC	519	521	CGC	22;22;23	C;G;C	22;22;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1118	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2465	24.1	0	.	p	.	0	N238S	NONSYN	712	714	AAC	885	887	AGC	22;23;23	A;G;C	22;22;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1118	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2465	24.1	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1086	1088	GTG	24;25;24	G;T;G	24;23;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1118	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2465	24.1	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1149	1151	AAC	10;10;9	A;A;C	10;9;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1118	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2465	24.1	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1194	1196	GTC	28;29;29	G;T;C	28;29;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1118	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2465	24.1	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1224	1226	ATA	32;31;31	A;T;A	32;31;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1118	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2465	24.1	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1332	1334	TCT	24;23;23	T;C;T	24;23;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1118	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2465	24.1	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1719	1721	GCG	24;24;24	G;C;G	24;24;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1118	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2465	24.1	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1932	1934	ATC	25;26;25	A;T;C	24;26;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	770	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2037	20.1	0	.	p	.	0	S129A	NONSYN	385	387	TCA	664	666	GCG	22;21;22	G;C;G	20;20;21	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	770	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2037	20.1	0	.	p	.	0	A187T	NONSYN	559	561	GCC	838	840	ACC	32;32;32	A;C;C	32;32;32	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	770	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2037	20.1	0	.	p	.	0	H211R	NONSYN	631	633	CAC	910	912	CGC	18;18;18	C;G;C	18;18;18	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	770	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2037	20.1	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1027	1029	GCT	34;34;32	G;C;T	33;34;32	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	770	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2037	20.1	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1111	1113	AAA	14;14;12	A;A;A	13;13;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	770	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2037	20.1	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1129	1131	CGA	18;18;19	C;G;A	17;17;18	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	770	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2037	20.1	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1294	1296	GCC	19;19;19	G;C;C	19;19;19	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	770	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2037	20.1	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1306	1308	GAT	16;17;18	G;A;T	16;17;18	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	770	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2037	20.1	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1723	1725	GCT	17;17;14	G;C;T	16;17;14	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2224	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3905	30.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1541	1543	AAG	22;23;22	A;A;G	22;23;21	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2224	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3905	30.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2618	2620	CTG	26;25;24	C;T;G	26;24;23	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	158	mgrB	144	144	100.0	mgrB.l15.c17.ctg.2	161	26.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1408	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1991	37.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	994	996	AAC	36;36;36	A;A;C	36;36;36	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1408	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1991	37.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1540	1542	ATA	34;33;33	A;T;A	34;33;33	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	938	murA_12	1260	1260	98.49	murA_12.l6.c4.ctg.1	1723	28.9	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1329	1331	GAT	53;50;49	G;A;T	52;50;49	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	938	murA_12	1260	1260	98.49	murA_12.l6.c4.ctg.1	1723	28.9	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1332	1334	CTG	49;48;42	C;T;G	49;48;42	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	827	17.2	0	.	p	.	0	R27C	NONSYN	79	81	CGT	250	252	TGT	20;19;20	T;G;T	20;19;20	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	827	17.2	0	.	p	.	0	I117T	NONSYN	349	351	ATC	520	522	ACC	12;12;13	A;C;C	12;12;13	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	827	17.2	1	SNP	p	R15C	0	.	.	43	45	CGC	214	216	CGC	34;33;33	C;G;C	34;32;33	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	379	98.94	nfsA.l15.c4.ctg.1	827	17.2	1	SNP	p	S33R	0	.	.	97	99	AGC	268	270	AGC	22;22;22	A;G;C	22;22;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	827	14.8	0	.	p	.	0	G187D	NONSYN	559	561	GGC	416	418	GAC	19;18;18	G;A;C	19;18;18	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	827	14.8	1	SNP	p	G131D	0	.	.	391	393	GGC	248	250	GGC	24;24;24	G;G;C	24;24;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	827	14.8	1	SNP	p	R203C	0	.	.	607	609	CGT	464	466	CGT	34;34;33	C;G;T	34;34;33	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	513	506	nfsA	723	353	99.15	nfsA.l15.c4.ctg.2	827	14.8	1	SNP	p	R203L	0	.	.	607	609	CGT	464	466	CGT	34;34;33	C;G;T	34;34;33	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	948	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1368	35.4	0	.	p	.	0	D312E	NONSYN	934	936	GAT	972	974	GAG	34;36;35	G;A;G	34;35;35	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	948	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1368	35.4	1	SNP	p	G141E	0	.	.	421	423	GGT	459	461	GGT	33;32;33	G;G;T	33;32;33	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	948	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1368	35.4	1	SNP	p	G141D	0	.	.	421	423	GGT	459	461	GGT	33;32;33	G;G;T	33;32;33	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	948	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1368	35.4	1	SNP	p	R154D	0	.	.	460	462	CGT	498	500	CGT	38;39;39	C;G;T	37;39;39	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	948	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1368	35.4	1	SNP	p	R154A	0	.	.	460	462	CGT	498	500	CGT	38;39;39	C;G;T	37;39;39	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1654	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2854	30.9	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1914	1916	GTG	47;46;47	G;T;G	47;45;47	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1654	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2854	30.9	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1941	1943	TCG	41;44;44	T;C;G	36;41;42	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1654	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2854	30.9	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2556	2558	AAC	20;20;20	A;A;C	20;19;20	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1654	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2854	30.9	1	SNP	p	A85T	0	.	.	253	255	GCG	570	572	GCG	33;34;35	G;C;G	31;33;32	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1654	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2854	30.9	1	SNP	p	D111H	0	.	.	331	333	GAT	648	650	GAT	37;37;37	G;A;T	37;37;37	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1654	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2854	30.9	1	SNP	p	S129P	0	.	.	385	387	TCC	702	704	TCC	32;32;33	T;C;C	32;32;33	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	1066	parE_1	1893	1760	97.44	parE_1.l15.c4.ctg.1	2065	24.9	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1284	1286	AAC	26;26;26	A;A;C	26;26;26	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	1066	parE_1	1893	1760	97.44	parE_1.l15.c4.ctg.1	2065	24.9	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1293	1295	GAT	37;37;36	G;A;T	37;37;36	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	1066	parE_1	1893	149	98.66	parE_1.l15.c4.ctg.3	169	18.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1060	patA	1380	1380	99.78	patA.l6.c4.ctg.1	2031	27.6	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	923	925	CAG	31;29;31	C;A;G	31;29;31	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1060	patA	1380	1380	99.78	patA.l6.c4.ctg.1	2031	27.6	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1397	1399	GAT	39;39;39	G;A;T	38;38;38	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2840	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4466	33.8	1	SNP	p	V146F	0	.	.	436	438	GTT	661	663	GTT	37;39;38	G;T;T	37;39;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2840	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4466	33.8	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1762	1764	CAG	35;31;32	C;A;G	35;30;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2840	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4466	33.8	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1762	1764	CAG	35;31;32	C;A;G	35;30;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2840	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4466	33.8	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1801	1803	CAC	37;37;36	C;A;C	37;37;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2840	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4466	33.8	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1810	1812	CGT	34;31;29	C;G;T	34;31;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2840	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4466	33.8	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1810	1812	CGT	34;31;29	C;G;T	34;31;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2840	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4466	33.8	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1816	1818	TCC	27;28;26	T;C;C	27;28;26	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2840	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4466	33.8	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1822	1824	CTC	23;23;22	C;T;C	23;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2840	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4466	33.8	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1912	1914	ACC	29;29;29	A;C;C	29;29;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2840	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4466	33.8	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1915	1917	CCT	28;29;32	C;C;T	28;29;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2840	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4466	33.8	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2284	2286	CGT	42;40;40	C;G;T	41;39;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	518	264.4	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	206	A	202	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	518	264.4	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	206	A	202	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	518	264.4	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	206	A	202	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	0	.	n	.	0	A226G	SNP	226	226	A	458	458	G	242	G	242	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	0	.	n	.	0	C719T	SNP	719	719	C	951	951	T	219	T,C,A	101,117,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	1	SNP	n	A794T	0	.	.	794	794	A	1026	1026	A	253	A	247	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	1	SNP	n	A794G	0	.	.	794	794	A	1026	1026	A	253	A	247	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	1	SNP	n	G926T	0	.	.	926	926	G	1158	1158	G	242	G	242	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	1	SNP	n	G926C	0	.	.	926	926	G	1158	1158	G	242	G	242	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	1	SNP	n	G926A	0	.	.	926	926	G	1158	1158	G	242	G	242	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	0	HET	.	.	.	T90C	.	90	90	T	322	322	T	212	T,C	166,42	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	0	HET	.	.	.	A250T	.	250	250	A	482	482	A	213	A,T	163,46	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	0	HET	.	.	.	G474A	.	474	474	G	706	706	G	251	G,A	189,57	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	0	HET	.	.	.	A253T,C	.	253	253	A	485	485	A	213	A,T,C	164,47,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	0	HET	.	.	.	C194T	.	194	194	C	426	426	C	230	C,T	190,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	0	HET	.	.	.	A79G	.	79	79	A	311	311	A	222	A,G	173,45	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	0	HET	.	.	.	T273A	.	273	273	T	505	505	T	212	T,A	155,52	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.3	1233	203.1	0	HET	.	.	.	C183T,G	.	183	183	C	415	415	C	201	C,T,G	140,58,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	142	100.0	rrsB+.l15.c30.ctg.4	142	58.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.7	142	42.0	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	76	A	76	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.7	142	42.0	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	77	C	75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.7	142	42.0	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	77	C,A	75,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.7	142	42.0	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	79	G	78	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.7	142	42.0	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	73	G	73	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8144	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.7	142	42.0	0	.	n	.	0	C1038T	SNP	1038	1038	C	90	90	T	70	T	69	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	480	sat_1	525	525	100.0	sat_1.l15.c30.ctg.1	1076	23.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	372	soxR	465	465	100.0	soxR.l15.c4.ctg.1	970	20.4	1	SNP	p	R20H	0	.	.	58	60	CGC	351	353	CGC	26;26;28	C;G;C	26;26;28	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	372	soxR	465	465	100.0	soxR.l15.c4.ctg.1	970	20.4	1	SNP	p	G121D	0	.	.	361	363	GGT	654	656	GGT	34;34;33	G;G;T	34;34;33	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	274	soxS_1	324	324	99.69	soxS_1.l6.c30.ctg.1	982	15.0	1	SNP	p	A12S	0	.	.	34	36	GCA	356	358	GCA	33;33;33	G;C;A	33;33;33	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	539	1298	APH_3____Ib+	804	804	99.88	APH_3____Ib+.l6.c4.ctg.1	1440	47.8	0	.	p	.	0	P121Q	NONSYN	361	363	CCG	636	638	CAG	73;71;71	C;A;G	72;70;71	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	1462	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c4.ctg.1	1466	53.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	1064	sul2	816	816	100.0	sul2.l15.c4.ctg.1	1465	38.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	1462	tetA	1200	1200	100.0	tetA.l15.c4.ctg.1	1833	42.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	938	tetR	651	651	100.0	tetR.l15.c30.ctg.1	1107	44.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1142	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	2053	29.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
